How Regeneron Is Benefiting From Continued Sanofi Investments

Developing drugs is expensive. Just ask executives at Regeneron Pharmaceuticals Inc., a New York-based drug developer. They will describe the high-risk and high-reward world of bringing a drug to market. They will also outline an emerging trend among businesses seeking to outsource that R&D cost.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news